EUVIMEDEUVIMED entdecken
Crossref

Sacubitril/valsartan promotes white adipose tissue browning in rats with metabolic syndrome through activation of mTORC1

Marina Nikolic, Nevena Jeremic iD, Nevena Lazarevic, Aleksandra Stojanovic, Andjela Milojevic Samanovic, Jovana Novakovic, Vladimir Zivkovic, Milos Nikolic, Nikola Nedeljkovic, Slobodanka Mitrovic, Vladimir Jakovljevic

BioFactors · 2024

DOI: 10.1002/biof.2040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Marina Nikolic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. Hauptthemen laut MEDLINE: Valsartan, Biphenyl Compounds, Adipose Tissue, White, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Faculty of Medical Science, University of Kragujevac, Ministry of Science, Technological Development and Innovation, Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to their usual use in the treatment of cardiovascular disease, weak evidence is available for the potential of combined use of neprilysin inhibitor (sacubitril) and AT1 receptor antagonist (valsartan) to promote browning of white adipose tissue (WAT) in rats with metabolic syndrome (MetS). This study involved 32 male Wistar albino rats divided into four groups: CTRL—healthy control rats; ENT—healthy rats treated with sacubitril/valsartan; MS—rats with MetS; MS + ENT—rats with MetS treated with sacubitril/valsartan. After finishing the experimental protocol, different WAT depots were isolated for further analysis of molecular pathways. Molecular docking and molecular dynamics studies were used for in silico assessment of the binding affinity of sacubitril and valsartan towards subunits of mechanistic target of rapamycin complex 1 (mTORC1). Sacubitril/valsartan treatment markedly diminished morphological changes in adipose tissue, resulting in smaller lipid size and multilocular lipid droplet structure in WAT. We showed significantly higher protein expression of uncoupling protein‐1 (UCP‐1) and mTORC1 in WAT of MS + ENT rats, correlating with increased relative gene expression of browning‐related markers in tissue of rats treated with sacubitril/valsartan compared with MS group of rats. In silico analysis showed that sacubitrilat and valsartan exhibited the highest binding affinity against mTOR and mLST8, forming stable complexes with these mTORC1 subunits. The observed results confirmed strong potential of combined sacubitril/valsartan treatment to increase browning markers expression in different WAT depots in MetS condition and to form permanent complexes with mTOR and mLST8 subunits over the time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanBiphenyl CompoundsAdipose Tissue, WhiteMetabolic SyndromeDrug CombinationsAminobutyratesRats, WistarMechanistic Target of Rapamycin Complex 1TetrazolesMolecular Docking SimulationAnimalsMaleRatsAdipose Tissue, BrownUncoupling Protein 1Molecular Dynamics SimulationNeprilysin

Stichwörter der Autor:innen

adipose tissuebrowningmolecular dockingsacubitrilvalsartan

Substanzen

ValsartanBiphenyl CompoundsDrug CombinationsAminobutyratessacubitril and valsartan sodium hydrate drug combinationMechanistic Target of Rapamycin Complex 1TetrazolesUncoupling Protein 1Neprilysin

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Center of Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Kragujevac, Serbia.
  • Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
  • Department of Human Pathology, 1st Moscow State Medical, University IM Sechenov, Moscow, Russia.
  • Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

ORCID-Profile: Nevena Jeremic

Förderung

  • Faculty of Medical Science, University of Kragujevac
  • Ministry of Science, Technological Development and Innovation, Republic of Serbia

Zitieren

APA

Nikolic, M., Jeremic, N., Lazarevic, N., Stojanovic, A., Milojevic Samanovic, A., Novakovic, J., Zivkovic, V., Nikolic, M., Nedeljkovic, N., Mitrovic, S., & Jakovljevic, V. (2024). Sacubitril/valsartan promotes white adipose tissue browning in rats with metabolic syndrome through activation of mTORC1. BioFactors. https://doi.org/10.1002/biof.2040

Vancouver

Nikolic M, Jeremic N, Lazarevic N, Stojanovic A, Milojevic Samanovic A, Novakovic J, et al. Sacubitril/valsartan promotes white adipose tissue browning in rats with metabolic syndrome through activation of mTORC1. BioFactors. 2024. doi:10.1002/biof.2040

BibTeX
@article{Nikolic2024,
  author = {Nikolic, Marina and Jeremic, Nevena and Lazarevic, Nevena and Stojanovic, Aleksandra and Milojevic Samanovic, Andjela and Novakovic, Jovana and Zivkovic, Vladimir and Nikolic, Milos and Nedeljkovic, Nikola and Mitrovic, Slobodanka and Jakovljevic, Vladimir},
  title = {Sacubitril/valsartan promotes white adipose tissue browning in rats with metabolic syndrome through activation of mTORC1},
  journal = {BioFactors},
  year = {2024},
  doi = {10.1002/biof.2040}
}
Kostenlos starten →